Objective: The aim: The study was aimed to compare the efficiency of intrathyroid steroid injection to oral steroid intake in patients with subacute thyroiditis.
Patients And Methods: Materials and methods: 32 patients with subacute thyroiditis with insufficient result from NSAIDs treatment were randomly divided into two groups. The 1st group received two intrathyroid steroid injections, the 2nd group received oral prednisone. The results of the treatment were evaluated via ultrasound and evaluation of ESR and CRP at 0, 2, 4, 8 and 16 weeks of treatment.
Results: Results: Patients of the 1st group showed much faster result at the ultrasound compared to the 2nd group: mean decrease in hypoechogenity area 44,42% vs 16,35% at week 2, p < 0,001; 93,29% vs 75,98% at week 4, p < 0,001; 97,8% vs 95,24% at week 8, p = 0,4; mean decrease in ESR 66,34% vs 51,92% at week 2, p = 0,023; 84,43% vs 74,94% at week 4, p = 0,023; mean decrease in CRP 26,53% vs 20,77% at week 2, p = 0,024, 33,77% vs 29,98%, at week 4, p = 0,026. No side effects were noted during the treatment of patients of the 1st group.
Conclusion: Conclusions: Compared to oral steroid intake intrathyroid steroid injection is faster, safer and generally better tolerated by patients.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Acute Thyrotoxic Myopathy Combined with Neck Pain: A Case Report.
Neuro Endocrinol Lett
October 2023
Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Article Synopsis
- Acute thyrotoxic myopathy (ATM) is a rare but serious complication of thyrotoxicosis, typically presenting with bulbar paralysis, and this report highlights the first known Chinese patient with ATM and neck pain.
- The 23-year-old patient experienced progressive weakness and painful thyroid swelling and was diagnosed with ATM, chronic thyrotoxic myopathy, and Graves' ophthalmopathy due to Graves' disease.
- Treatment involved a combination of low-dose glucocorticoids, antithyroid drugs, and an intrathyroidal steroid injection, leading to significant improvement without recurrence of symptoms.
Real-world effect of the treatment for painful subacute thyroiditis: The combined injection of lidocaine and triamcinolone using an insulin pen.
Arch Endocrinol Metab
March 2023
Department of Endocrinology and Metabolism, Laibin People's Hospital, Laibin 546100, China,
Objective: : Intrathyroidal injection using an insulin pen filled with a mixture of lidocaine and triamcinolone acetonide is a therapy for subacute thyroiditis (SAT) reported by us previously. We aimed to evaluate the clinical efficacy of ultrasound-guided intrathyroidal injection in the treatment of SAT.
Subjects And Methods: A total of 93 patients with SAT completed the study.
Management of Subacute Thyroiditis - A Systematic Review of Current Treatment Protocols.
Int J Gen Med
August 2022
Department of Surgery, Netaji Subhash Chandra Bose Medical College Jabalpur, Jabalpur, India.
Purpose: This systematic review endeavors to find an effective treatment protocol for subacute thyroiditis (SAT) to minimize side effects, recurrence and long-term hypothyroidism.
Materials And Methods: We analyzed available original studies on treatment protocols for SAT. A thorough literature search was performed on the following online databases PubMed, Cochrane library nd Google Scholar using appropriate keywords for choosing relevant articles.
PAINFUL SUBACUTE THYROIDITIS TREATMENT APPROACH.
Wiad Lek
September 2021
SUMY LASER CLINIC, SUMY, UKRAINE.
Objective: The aim: The study was aimed to compare the efficiency of intrathyroid steroid injection to oral steroid intake in patients with subacute thyroiditis.
Patients And Methods: Materials and methods: 32 patients with subacute thyroiditis with insufficient result from NSAIDs treatment were randomly divided into two groups. The 1st group received two intrathyroid steroid injections, the 2nd group received oral prednisone.
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of I during radioiodine therapy of Graves' disease.
Endocrine
July 2021
Department of Nuclear Medicine, Goethe University Frankfurt, University Hospital, Theodor Stern Kai 7, D-60590, Frankfurt/Main, Germany.
Aim: Radioiodine therapy (RIT) may trigger the development of Graves' ophthalmopathy (GO) or exacerbate pre-existing subclinical GO. Therefore, glucocorticoid administration is recommended for patients with pre-existing GO. Aim of this study was to analyze the influence of glucocorticoid therapy with methylprednisolone on intratherapeutic effective half-life (EHL) of radioiodine-131 in patients with Graves' disease (GD) as recent studies showed an effect for prednisolone.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!